Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01613885 · ClinicalTrials.gov registry record
Understanding and Diagnosing Allergic Disease in Twins
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 340
- Enrollment target
NCT01613885: Completed study, sponsored by Stanford University.
NCT01613885 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 340 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01613885 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 340 participants
- Enrollment target
Study Summary
The purpose of this study is to gain better understanding of how the immune system works in twins with and without allergic disease. Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2010-08 |
| Est. Completion | 2019-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01613885
The ClinicalTrials.gov registry entry for NCT01613885 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT01613885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01613885 about?
NCT01613885 is a clinical study titled "Understanding and Diagnosing Allergic Disease in Twins". The purpose of this study is to gain better understanding of how the immune system works in twins with and without allergic disease. Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies.
What is the current status of trial NCT01613885?
This trial is currently completed. The enrollment target is 340 participants. The study started on 2010-08. Estimated completion is 2019-10.
What interventions are being tested in trial NCT01613885?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT01613885?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.